Related references
Note: Only part of the references are listed.Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRP
Eleonora Elhalem et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure-activity relationships and biological activities
Virpi Talman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP
Lia C. Garcia et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
C1 Domains: Structure and Ligand-Binding Properties
Joydip Das et al.
CHEMICAL REVIEWS (2014)
Evidence for a role of MRCK in mediating He La cell elongation induced by the Cl domain ligand HMI-1a3
Virpi Talman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Total Syntheses of (-)-Pyrimidoblamic Acid and P-3A
Adam S. Duerfeldt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Protein kinase C and cancer: what we know and what we do not
R. Garg et al.
ONCOGENE (2014)
Cycloadditions of Noncomplementary Substituted 1,2,3-Triazines
Erin D. Anderson et al.
ORGANIC LETTERS (2014)
The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cells
Virpi Talman et al.
PHARMACOLOGICAL RESEARCH (2013)
Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Gustav Boije af Gennas et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
C1 Domain-Targeted Isophthalate Derivatives Induce Cell Elongation and Cell Cycle Arrest in HeLa Cells
Virpi Talman et al.
PLOS ONE (2011)
Protein kinase C intervention-the state of play
Jon Roffey et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
ChemGPS-NPWeb: chemical space navigation online
Josefin Rosen et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Design, Synthesis, and Biological Activity of Isophthalic Acid Derivatives Targeted to the C1 Domain of Protein Kinase C
Gustav Boije af Gennas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Wealth of opportunity - The C1 domain as a target for drug development
P. M. Blumberg et al.
CURRENT DRUG TARGETS (2008)
The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot for PKC affinity
Paul A. Wender et al.
ORGANIC LETTERS (2008)
Targeting the protein kinase C family: are we there yet?
Helen J. Mackay et al.
NATURE REVIEWS CANCER (2007)
ChemGPS-NP: Tuned for navigation in biologically relevant chemical space
Josefin Larsson et al.
JOURNAL OF NATURAL PRODUCTS (2007)
PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease
Daniel L. Alkon et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Phorbol esters: Structure, biological activity, and toxicity in animals
Gunjan Goel et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Expanding the ChemGPS chemical space with natural products
J Larsson et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Toward the development of new medicinal leads with selectivity for protein kinase C isozymes
K Irie et al.
CHEMICAL RECORD (2005)
Characterization of the interaction of ingenol 3-angelate with protein kinase C
N Kedei et al.
CANCER RESEARCH (2004)
Screening of natural compounds and their derivatives as potential protein kinase C inhibitors
P Tammela et al.
DRUG DEVELOPMENT RESEARCH (2004)
Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C)
DM Sigano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily
L Shao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
K Nacro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
